Immunotherapy may aid ovarian cancer chemotherapy resistance, study suggests

May 24, 2016 12:59 PM

17 0

Immunotherapy may aid ovarian cancer chemotherapy resistance, study suggests

Ovarian cancer is one of the deadliest cancers among American women, in part because the cancer develops a resistance to chemotherapy. In a new study, researchers at the University of Michigan at Ann Arbor suggest that adding immunotherapy to chemotherapy may reverse chemotherapy resistance.

Typically, ovarian cancer is treated with cisplatin, a platinum-based chemotherapy. The platinum builds up in the nucleus of cancer cells and stops them from dividing, resulting in resistance to the treatment and survival of the cancer cells, Medical News Today reported.

Also read: Synergy Pharma's irritable bowel drug succeeds in key study

Read more

To category page

Loading...